The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma
Open accessAbstract
Vulvar squamous cell carcinoma (VSCC) accounts for >90% of the malignant tumours of the vulva. Most VSCC s originate in intraepithelial lesions, named vulvar intraepithelial neoplasia (VIN), that precede the development of VSCC by a variable period of time. Strong evidence has accumulated showing that there are two different aetiopathogenic pathways for the development of VSCC and VIN, one associated with infection by human papillomavirus (HPV), and a second independent of HPV infection. These two different types of VSCC have different epidemiological, pathological and clinical characteristics, and should therefore be considered as two separate entities. Histologically, HPV‐associated VSCC s are of the basaloid or warty type, and arise from VIN of the usual type. Inactivation of p53 and the retinoblastoma tumour suppressor gene product by the viral gene products E 6 and E 7 is involved in the process of malignant transformation. HPV‐independent VSCC s are histologically keratinizing, are associated with differentiated VIN and lichen sclerosus, and frequently show mutations of p53. p16INK4a and p53 immunostaining can be useful for classifying VSCC into HPV‐associated or HPV‐independent. Although large, multicentre studies are needed to definitively assess the involvement of HPV in the prognosis of VSCC, most studies have not found clear differences in survival between HPV‐associated and HPV‐independent tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Walker, R. A. (2005) · Histopathology · doi:10.1111/j.1365-2559.2004.02026.x · Cited by 839
Smeets, S. J., Hesselink, A. T., Speel, E. M., Haesevoets, A., Snijders, P. J. F., Pawlita, M., Meijer, C. J. L. M., Braakhuis, B. J. M., Leemans, C. R., & Brakenhoff, R. H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22980 · Cited by 749
Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S., Tramm, T., Alsner, J., & Overgaard, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2853 · Cited by 612
Garland, S. M., Steben, M., Sings, H. L., James, M., Lu, S., Railkar, R., Barr, E., Haupt, R. M., & Joura, E. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597071 · Cited by 532
Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDS
Chaturvedi, A. K., Madeleine, M. M., Biggar, R. J., & Engels, E. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp205 · Cited by 523
Trends in the Incidence of Invasive and In Situ Vulvar Carcinoma
Judson, P. L., Habermann, E. B., Baxter, N. N., Durham, S. B., & Virnig, B. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000210268.57527.a1 · Cited by 469
Sideri, M., Jones, R. W., Wilkinson, E. J., Preti, M., Heller, D. S., Scurry, J., Haefner, H., & Neill, S. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201921.69949.10 · Cited by 339
van Seters, M., van Beurden, M., & de Craen, A. J. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.012 · Cited by 338
Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187301.76283.7f · Cited by 273
Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors
Smith, J. S., Backes, D. M., Hoots, B. E., Kurman, R. J., & Pimenta, J. M. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31819bd6e0 · Cited by 273
Carlson, J. A., Ambros, R., Malfetano, J., Ross, J., Grabowski, R., Lamb, P., Figge, H., & Mihm, M. C. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90198-8 · Cited by 248
Bergeron, C., Ordi, J., Schmidt, D., Trunk, M. J., Keller, T., & Ridder, R. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpxsvcdz3d5mzm · Cited by 231
Self-citationJoura, E. A., Lösch, A., Haider-Angeler, M.-G., Breitenecker, G., & Leodolter, S. (2000) · PubMed · Cited by 231
Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil
Li, W., Thompson, C. H., O'Brien, C. J., McNeil, E. B., Scolyer, R. A., Cossart, Y. E., Veness, M. J., Walker, D. M., Morgan, G. J., & Rose, B. R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11261 · Cited by 230
Abdel‐Hady, E., Martin‐Hirsch, P. L., Duggan-Keen, M. F., Stern, P. L., Moore, J., Corbitt, G., Kitchener, H. C., & HAMPSON, I. N. (2001) · PubMed · Cited by 192
Conley, L. J., Ellerbrock, T. V., Bush, T. J., Chiasson, M. A., Sawo, D., & Wright, T. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07368-3 · Cited by 186
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter, J. J., Madeleine, M. M., Shera, K. A., Schwartz, S. M., Cushing‐Haugen, K. L., Wipf, G. C., Porter, P. L., Daling, J. R., McDougall, J. K., & Galloway, D. A. (2001) · PubMed · Cited by 182
Tumors of the Cervix, Vagina, and Vulva
Kurman, R. J., Ronnett, B. M., Sherman, M. E., & Wilkinson, E. J. (2010) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/9781933477114 · Cited by 168
Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study
Carli, P., Cattaneo, A., Magnis, A. D., Biggeri, A., Taddei, G., & Giannotti, B. (1995) · European Journal of Cancer Prevention · doi:10.1097/00008469-199512000-00008 · Cited by 166
p16 Overexpression Identifies HPV-positive Vulvar Squamous Cell Carcinomas
Santos, M., Landolfi, S., Olivella, A., Lloveras, B., Klaustermeier, J., Suárez, H., Alòs, L., Puig-Tintoré, L. M., Campo, E., & Ordi, J. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213251.82940.bf · Cited by 162
Self-citationSideri, M., Jones, R. W., Wilkinson, E. J., Preti, M., Heller, D. S., Scurry, J., Haefner, H. K., & Neill, S. (2005) · PubMed · Cited by 155
The Etiologic Role of HPV in Vulvar Squamous Cell Carcinoma Fine Tuned
van de Nieuwenhof, H. P., van Kempen, L. C. L. T., de Hullu, J. A., Bekkers, R. L. M., Bulten, J., Melchers, W. J. G., & Massuger, L. F. A. G. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0209 · Cited by 147
Santos, M., Montagut, C. O., Mellado, B., García, Á., y Cajal, S. R., Cardesa, A., Puig-Tintoré, L. M., & Ordï, J. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000130108.03231.89 · Cited by 143
Vulvar Squamous Cell Carcinoma and Papillomaviruses: Indications for Two Different Etiologies
Hørding, U., Junge, J., Daugaard, S., Lundvall, F., Poulsen, H., & Bock, J. E. (1994) · Gynecologic Oncology · doi:10.1006/gyno.1994.1039 · Cited by 143
Pinto, Á. P., Miron, A., Yassin, Y., Monte, N. M., Woo, T. Y. C., Mehra, K. K., Medeiros, F., & Crum, C. P. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.179 · Cited by 133
p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias
Riethdorf, S., Neffen, E., Čviko, A., Löning, T., Crum, C. P., & Riethdorf, L. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.09.004 · Cited by 121
Squamous Vulvar Intraepithelial Neoplasia
Preti, M., van Seters, M., Sideri, M. G., & van Beurden, M. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000181738.37911.03 · Cited by 113
Report of the ISSVD terminology committee
Wilkinson, E. J., Kneale, B., & Lynch, P. J. (1986) · Cited by 112
Hoevenaars, B. M., van der Avoort, I. A. M., de Wilde, P. C. M., Massuger, L. F. A. G., Melchers, W. J. G., de Hullu, J. A., & Bulten, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23857 · Cited by 100
Bekkers, R. L. M., Massuger, L. F. A. G., Bulten, J., & Melchers, W. J. G. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.416 · Cited by 96
Two Distinct Pathways to Development of Squamous Cell Carcinoma of the Vulva
Ueda, Y., Enomoto, T., Kimura, T., Yoshino, K., Fujita, M., & Kimura, T. (2010) · Journal of Skin Cancer · doi:10.1155/2011/951250 · Cited by 93
BD ProEx C: A Sensitive and Specific Marker of HPV-associated Squamous Lesions of the Cervix
Badr, R., Walts, A. E., Chung, F., & Bose, S. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815bbb69 · Cited by 90
TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva
Rolfe, K. J., MacLean, A., Crow, J. C., Benjamin, E. O., Reid, W. M. N., & Perrett, C. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601444 · Cited by 88
Kim, Y., Thomas, N. F., Kessis, T. D., Wilkinson, E. J., Hedrick, L., & Cho, K. R. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90113-6 · Cited by 83
Human Papillomavirus in Squamous Cell Carcinoma of the Vulva by Polymerase Chain Reaction
Iwasawa, A. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00376-6 · Cited by 59
Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node
Lindell, G., Näsman, A., Jonsson, C., Ehrsson, R. J., Jacobsson, H., Gemzell‐Danielsson, K., Dalianis, T., Källström, B. N., & Larson, B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.12.031 · Cited by 59
Role of TP53 Mutations in Vulvar Carcinomas
Choschzick, M., Hantaredja, W., Tennstedt, P., Gieseking, F., Woelber, L. L., & Simon, R. (2011) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3182184c7a · Cited by 58
Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina
Alonso, I., Félix, A., Torné, A., Fusté, V., Pino, M. L. D., Castillo, P., Balasch, J., Pahisa, J., Ríos, J., & Ordï, J. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.12.449 · Cited by 57
Rosenthal, A. N., Ryan, A., Hopster, D. J., & Jacobs, I. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10362 · Cited by 53
Terlou, A., Blok, L. J., Helmerhorst, T. J. M., & van Beurden, M. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016341003739575 · Cited by 46
Jin, Z., Wallace, L. M., Harper, S. Q., & Yang, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169581 · Cited by 44
Allelic Loss in Human Papillomavirus-Positive and -Negative Vulvar Squamous Cell Carcinomas
Pinto, Á. P., Lin, M.-C., Mutter, G. L., Sun, D., Villa, L. L., & Crum, C. P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65353-9 · Cited by 42
Goffin, F., Mayrand, M., Gauthier, P., Alobaid, A. S., Lussier, C., Provencher, D. M., Drouin, P., Franco, E. L., & Coutlée, F. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20628 · Cited by 42
Bonvicini, F., Venturoli, S., Ambretti, S., Paterini, P., Santini, D., Ceccarelli, C., Zerbini, M., & Musiani, M. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20420 · Cited by 40
p14ARF, a Prognostic Predictor in HPV-Negative Vulvar Carcinoma
Knopp, S., Nesland, J. M., Trope, C. G., & Holm, R. (2006) · American Journal of Clinical Pathology · doi:10.1309/e9e8y9wg5qe3lk29 · Cited by 34
Tumor Proliferation in Squamous Cell Carcinoma of the Vulva
Hantschmann, P., Lampe, B., Beysiegel, S., et al. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200010000-00011 · Cited by 26
Aulmann, S., Schleibaum, J., Penzel, R., Schirmacher, P., Gebauer, G., & Sinn, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.056275 · Cited by 26
Tsimplaki, E., Argyri, E., Michala, L., Kouvousi, M., Apostolaki, A., Magiakos, G., Papassideri, I. S., & Panotopoulou, E. (2011) · Journal of Oncology · doi:10.1155/2012/893275 · Cited by 25
Cell cycle regulation and proliferation in lichen sclerosus
Gambichler, T., Kammann, S., Tigges, C., Kobus, S., Skrygan, M., Meier, J. J., Köhler, C. U., Scola, N., Stücker, M., Bechara, F. G., et al. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.003 · Cited by 24
Kowalewska, M., Szkoda, M. T., Radziszewski, J., Ptaszyński, K., Bidziński, M., & SIEDLECKI, J. A. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181d320f1 · Cited by 17
Cited by
de Sanjosé, S., Alemany, L., Ordi, J., Tous, S., Alejo, M., Bigby, S. M., Joura, E. A., Maldonado, P., Laco, J., Bravo, I. G., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.033 · Cited by 394
Self-citation
Metadata
- Authors
- del Pino, M., Rodriguez‐Carunchio, L., & Ordi, J.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2012-11-27
- Volume
- 62
- Issue
- 1
- Pages
- 161-175
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2110433517
- Cited by
- 322
- References
- 55
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.